Wedbush Starts NovoCure Ltd. (NVCR) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
JMP Securities Starts NovoCure Ltd. (NVCR) at Market Outperform
October 27, 2015 8:18 AM EDTJMP Securities initiated coverage on NovoCure Ltd. (NASDAQ: NVCR) with a Market Outperform rating and a price target of $43.00.
For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.
Shares of NovoCure Ltd. closed at $20.58 yesterday.
... MoreJPMorgan Starts NovoCure Ltd. (NVCR) at Overweight
October 27, 2015 8:11 AM EDTJPMorgan initiated coverage on NovoCure Ltd. (NASDAQ: NVCR) with an Overweight rating and a price target of $29.00.
For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.
Shares of NovoCure Ltd. closed at $20.58 yesterday.
... MoreNovocure (NVCR) Reports Q3 Loss of $2.09/Share
October 26, 2015 4:14 PM EDTNovocure (NASDAQ: NVCR) reported Q3 EPS of ($2.09), versus ($1.45) reported last year. Revenue for the quarter came in at $8.95 million, versus $4.37 million reported last year.
Third Quarter 2015 Operating Statistics
354 prescriptions were received in the quarter, an... More